Brett Davis

Brett serves as a US Chief Innovation Officer at Deloitte, leading the development of the organization’s product and solutions strategy, innovation investment prioritization, commercial enablement, as well as the establishment of new client and alliance co-venturing models across priority markets. In this role, Brett is responsible for supporting and managing Deloitte’s investments in creating impactful new businesses and platforms that help shape and transform industries responsibly, including Converge™ by Deloitte, Deloitte Ascend™, and Zora AI™ by Deloitte. 

Brett is a principal in Deloitte Consulting LLP and also serves as General Manager for Converge by Deloitte. Previously, Brett was the founder and General Manager of ConvergeHEALTH, a business unit focused on supporting the information-based transformation of life sciences and health care that he co-founded and launched in 2014. Through this work, he was responsible for managing Deloitte’s investment in new digital engagement and advanced analytics platforms to support the industry’s shift to value-based, personalized health care. Today, Deloitte’s ConvergeHEALTH platform supports millions of patients as well as leading biopharmaceutical and health care clients in their transformations in over 30 countries.

He has been a keynote speaker at numerous industry conferences including by the Healthcare Information and Management Systems Society, the American Medical Informatics Association, the Drug Information Association, the American Society of Clinical Oncology, the National Chamber of Commerce Health Summit, Personalized Medicine World Conference, Harvard Partners Personalized Medicine Conference, and the Annual National Quality Colloquium. Brett has published numerous white papers on the transformative impact of health information technology, and been quoted in publications such as the London Times, InformationWeek, Advanced Clinical Trials, Computer World, Health Data Management, and Bio-IT World.  He also sits on the External Advisory Boards of the Schreyer Honors College at The Pennsylvania State University (Penn State) and the University of Pennsylvania’s Division of Medical Ethics and Health Policy.

Prior to joining Deloitte, Davis held leadership roles in life sciences and health care at Oracle and IBM.